S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
'Knock at the Cabin' knocks off 'Avatar' at the box office
NASDAQ:SPRB

Spruce Biosciences - SPRB Short Interest Ratio & Short Volume

$2.91
-0.13 (-4.28%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
$2.80
$3.18
50-Day Range
$0.99
$3.09
52-Week Range
$0.95
$3.38
Volume
141,243 shs
Average Volume
4.17 million shs
Market Capitalization
$68.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.80

Spruce Biosciences Short Interest Data

Current Short Volume
1,210,000 shares
Previous Short Volume
683,100 shares
Change Vs. Previous Month
+77.13%
Dollar Volume Sold Short
$3.34 million
Short Interest Ratio / Days to Cover
0.9
Last Record Date
January 15, 2023
Outstanding Shares
23,560,000 shares
Float Size
12,070,000 shares
Short Percent of Float
10.02%
Today's Trading Volume
141,243 shares
Average Trading Volume
4,166,911 shares
Today's Volume Vs. Average
-96.61%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Spruce Biosciences ?

Sign up to receive the latest short interest report for Spruce Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SPRB Short Interest Over Time

SPRB Days to Cover Over Time

SPRB Percentage of Float Shorted Over Time

Spruce Biosciences (NASDAQ:SPRB) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/15/20231,210,000 shares $3.34 million +77.1%10.0%0.9 $2.76
12/30/2022683,100 shares $749,633.94 +16.1%5.6%0.5 $1.10
12/15/2022588,600 shares $588,600.00 +17.5%4.9%9.7 $1.00
11/30/2022500,900 shares $550,990.00 +52.3%4.1%9.3 $1.10
11/15/2022328,900 shares $345,345.00 +23.2%2.7%6.4 $1.05
10/31/2022267,000 shares $296,370.00 +211.9%2.2%7.9 $1.11
10/15/202285,600 shares $97,584.00 +40.1%0.7%2.6 $1.14
9/30/202261,100 shares $83,707.00 -19.5%0.5%2.2 $1.37
9/15/202275,900 shares $132,825.00 +22.0%0.6%1.7 $1.75
8/31/202262,200 shares $136,218.00 -13.6%0.5%1 $2.19
8/15/202272,000 shares $154,800.00 -31.8%0.6%0.5 $2.15
7/31/2022105,600 shares $195,360.00 +16.3%0.9%0.7 $1.85
7/15/202290,800 shares $171,612.00 -26.7%0.8%0.5 $1.89
6/30/2022123,900 shares $215,586.00 -71.2%1.0%0.7 $1.74
6/15/2022429,700 shares $687,520.00 +2.8%3.6%2.3 $1.60
5/31/2022417,900 shares $651,924.00 +8.2%3.5%2.2 $1.56
5/15/2022386,200 shares $525,232.00 -0.5%3.2%3.1 $1.36
4/30/2022388,300 shares $683,408.00 +2.5%3.5%2.8 $1.76
4/15/2022378,700 shares $802,844.00 +21.3%3.4%2.2 $2.12
3/31/2022312,100 shares $627,321.00 -5.1%3.5%1 $2.01
3/15/2022328,700 shares $608,095.00 -17.8%4.6%0.2 $1.85
2/28/2022399,900 shares $907,773.00 -4.4%5.6%0.1 $2.27
2/15/2022418,300 shares $962,090.00 -7.6%5.9%0.1 $2.30
1/31/2022452,600 shares $1.15 million -10.5%6.4%0.1 $2.54
1/15/2022505,400 shares $1.73 million -58.2%6.4%0.1 $3.43
12/31/20211,210,000 shares $5.40 million +78.7%17.1%0.3 $4.46
12/15/2021677,300 shares $1.69 million +28.4%9.6%0.2 $2.50
11/30/2021527,700 shares $1.36 million +10.8%7.5%3.9 $2.58
11/15/2021476,200 shares $2.09 million -0.7%6.8%4.4 $4.39
10/29/2021479,500 shares $2.28 million +2.0%6.8%7.7 $4.76
10/15/2021470,100 shares $2.11 million -3.0%6.0%9.6 $4.48
9/30/2021484,700 shares $2.91 million -10.5%6.2%11.2 $6.01
9/15/2021541,500 shares $3.91 million +1.3%7.0%10.3 $7.22
8/31/2021534,700 shares $4.10 million +0.6%6.9%8.7 $7.67
8/13/2021531,500 shares $4.08 million +9.3%6.9%8.9 $7.67
7/30/2021486,400 shares $4.48 million -1.6%6.3%6.9 $9.21
7/15/2021494,100 shares $4.91 million -3.1%6.4%6.1 $9.94
6/30/2021510,100 shares $5.72 million +5.6%6.6%6.4 $11.21
6/15/2021483,300 shares $5.62 million +6.5%6.2%6.8 $11.63
5/28/2021454,000 shares $6.42 million -1.9%5.9%6.4 $14.13













SPRB Short Interest - Frequently Asked Questions

What is Spruce Biosciences' current short interest?

Short interest is the volume of Spruce Biosciences shares that have been sold short but have not yet been covered or closed out. As of January 15th, traders have sold 1,210,000 shares of SPRB short. 10.02% of Spruce Biosciences' shares are currently sold short. Learn More on Spruce Biosciences' current short interest.

What is a good short interest ratio for Spruce Biosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SPRB shares currently have a short interest ratio of 1.0. Learn More on Spruce Biosciences's short interest ratio.

What is a good short interest percentage for Spruce Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.02% of Spruce Biosciences' floating shares are currently sold short.

Is Spruce Biosciences' short interest increasing or decreasing?

Spruce Biosciences saw a increase in short interest in January. As of January 15th, there was short interest totaling 1,210,000 shares, an increase of 77.1% from the previous total of 683,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Spruce Biosciences' float size?

Spruce Biosciences currently has issued a total of 23,560,000 shares. Some of Spruce Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Spruce Biosciences currently has a public float of 12,070,000 shares.

How does Spruce Biosciences' short interest compare to its competitors?

10.02% of Spruce Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Spruce Biosciences: Genprex, Inc. (3.44%), Anebulo Pharmaceuticals, Inc. (0.83%), HCW Biologics Inc. (0.16%), Mustang Bio, Inc. (0.39%), Galectin Therapeutics Inc. (4.69%), Ocuphire Pharma, Inc. (5.14%), Atreca, Inc. (8.56%), Unity Biotechnology, Inc. (4.64%), SELLAS Life Sciences Group, Inc. (5.84%), and Connect Biopharma Holdings Limited (0.22%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.43 billion), T. Rowe Price Group, Inc. ($2.26 billion), Coinbase Global, Inc. ($2.19 billion), Etsy, Inc. ($1.78 billion), Paramount Global ($1.77 billion), Old Dominion Freight Line, Inc. ($1.69 billion), United Rentals, Inc. ($1.53 billion), American Airlines Group Inc. ($1.52 billion), PG&E Co. ($1.48 billion), and Voya Financial, Inc. ($1.47 billion). View all of the most shorted stocks.

What does it mean to sell short Spruce Biosciences stock?

Short selling SPRB is an investing strategy that aims to generate trading profit from Spruce Biosciences as its price is falling. SPRB shares are trading down $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Spruce Biosciences?

A short squeeze for Spruce Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SPRB, which in turn drives the price of the stock up even further.

How often is Spruce Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SPRB, twice per month. The most recent reporting period available is January, 15 2023.



This page (NASDAQ:SPRB) was last updated on 2/5/2023 by MarketBeat.com Staff